1 | Mirikizumab (D11123) | [1] Mirikizumab Mirikizumab | [1] Mirikizumab
Mirikizumab
(D11123) 💬 | [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [3] 37 37, 96, 97 💬 |
2 | Mirikizumab IV (D11123) | [1] Mirikizumab Mirikizumab | [1] Mirikizumab
Mirikizumab
(D11123) 💬 | [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 97 97 💬 |
3 | Mirikizumab SC (D11123) | [1] Mirikizumab Mirikizumab | [1] Mirikizumab
Mirikizumab
(D11123) 💬 | [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 97 97 💬 |